Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch (CATCH)

Summary

This study is evaluating a new wearable heart monitor called HeartWatch. The goal is to see whether it records heart rhythm information as well as standard heart monitors that are currently used in clinics.

We are are currently looking for participants with Atrial Fibrillation.

People whose doctor has recommended, or may recommend, a heart monitor to check their heart rhythm may be able to take part. Participants in the study will wear the conventional heart monitor that is prescribed as part of their usual care. They will also wear the HeartWatch device so that researchers can compare the recordings from the two devices. The HeartWatch device is worn on the upper arm using a band. It continuously records heart rhythm data.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 22 to 99

Inclusion criteria:

You may be able to participate if:

1. You are at least 22 years old
2. You have a history or suspected history of high blood pressure, atrial fibrillation valvular heart disease, or heart disease

Exclusion criteria:

You may not be able to participate if:

1. You cannot safely wear the HeartWatch device on your upper arm.
2. You are unable to provide informed consent.
3. The research team determines during screening that the study is not appropriate for you.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Joel Angihan

Principal investigator:

F. Russell Quinn

Clinical trial:

Yes

REB-ID:

REB23-1676